Skip to main navigation Skip to search Skip to main content

NN5401-3816, A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and ad

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date12/20/13 → 06/15/15

Funding

  • Novo Nordisk Incorporated: $37,192.00